IDENIX PHARMACEUTICALS INC - FORM 10-K - EX-32.1 - EX-32.1 CEO CERT SECTION 906 - March 7, 2011

Attached files

file filename
10-K - FORM 10-K - IDENIX PHARMACEUTICALS INCc13549e10vk.htm
EX-31.1 - EX-31.1 CEO CERT SECTION 302 - IDENIX PHARMACEUTICALS INCc13549exv31w1.htm
EX-23.1 - EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP - IDENIX PHARMACEUTICALS INCc13549exv23w1.htm
EX-32.2 - EX-32.2 CFO CERT SECTION 906 - IDENIX PHARMACEUTICALS INCc13549exv32w2.htm
EX-21.1 - EXHIBIT 21.1 - IDENIX PHARMACEUTICALS INCc13549exv21w1.htm
EX-10.62 - EX-10.62 EMPLOYMENT LETTER, DATED NOVEMBER 30, 2010, BY AND BETWEEN THE REGISTRANT AND MARIA STAHL - IDENIX PHARMACEUTICALS INCc13549exv10w62.htm
EX-10.61 - EX-10.61 EMPLOYMENT LETTER, DATED DECEMBER 9, 2010, BY AND BETWEEN THE REGISTRANT AND DAVID N. STANDRING, PH.D. - IDENIX PHARMACEUTICALS INCc13549exv10w61.htm
EX-31.2 - EX-31.2 CFO CERT SECTION 302 - IDENIX PHARMACEUTICALS INCc13549exv31w2.htm
EX-10.60 - EX-10.60 EMPLOYMENT LETTER, DATED DECEMBER 8, 2010, BY AND BETWEEN THE REGISTRANT AND DOUGLAS L. MAYERS, M.D. - IDENIX PHARMACEUTICALS INCc13549exv10w60.htm
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Idenix Pharmaceuticals, Inc. (the “Company”) for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Ronald C. Renaud, Jr., President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 7, 2011
     
/s/ Ronald C. Renaud, Jr.
 
    
Ronald C. Renaud, Jr.
    
President and Chief Executive Officer
    
A signed original of this written statement required by Section 906 has been provided to Idenix Pharmaceuticals, Inc. and will be retained by Idenix Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

Stock widget

Investing forum

IDENIX PHARMACEUTICALS INC Reports